Shaker Financial Services’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $398K | Buy |
31,062
+7,632
| +33% | +$97.8K | 0.14% | 115 |
|
|
2025
Q1 | $297K | Buy |
+23,430
| New | +$297K | 0.12% | 132 |
|
|
2024
Q1 | – | Sell |
-61,683
| Closed | -$840K | – | 169 |
|
|
2023
Q4 | $840K | Sell |
61,683
-4,845
| -7% | -$66K | 0.34% | 85 |
|
|
2023
Q3 | $830K | Buy |
66,528
+1,342
| +2% | +$16.7K | 0.39% | 83 |
|
|
2023
Q2 | $883K | Sell |
65,186
-1,342
| -2% | -$18.2K | 0.39% | 82 |
|
|
2023
Q1 | $927K | Buy |
66,528
+1,500
| +2% | +$20.9K | 0.41% | 80 |
|
|
2022
Q4 | $924K | Buy |
65,028
+3,161
| +5% | +$44.9K | 0.43% | 71 |
|
|
2022
Q3 | $845K | Buy |
61,867
+5,000
| +9% | +$68.3K | 0.42% | 73 |
|
|
2022
Q2 | $809K | Buy |
56,867
+40,583
| +249% | +$577K | 0.39% | 71 |
|
|
2022
Q1 | $269K | Buy |
+16,284
| New | +$269K | 0.1% | 133 |
|
|
2021
Q3 | – | Sell |
-59,972
| Closed | -$1.29M | – | 154 |
|
|
2021
Q2 | $1.29M | Buy |
59,972
+40,441
| +207% | +$867K | 0.48% | 80 |
|
|
2021
Q1 | $385K | Buy |
19,531
+835
| +4% | +$16.5K | 0.15% | 135 |
|
|
2020
Q4 | $369K | Hold |
18,696
| – | – | 0.15% | 132 |
|
|
2020
Q3 | $329K | Hold |
18,696
| – | – | 0.18% | 123 |
|
|
2020
Q2 | $336K | Buy |
18,696
+2,660
| +17% | +$47.8K | 0.19% | 126 |
|
|
2020
Q1 | $240K | Buy |
+16,036
| New | +$240K | 0.16% | 134 |
|
|
2014
Q1 | – | Sell |
-52,133
| Closed | -$1.07M | – | 156 |
|
|
2013
Q4 | $1.07M | Buy |
52,133
+29,012
| +125% | +$593K | 0.74% | 50 |
|
|
2013
Q3 | $445K | Buy |
+23,121
| New | +$445K | 0.33% | 100 |
|